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Abstract
Idiopathic granulomatous mastitis (IGM) is a rare inflammatory breast disease. The etiology and treatment options
of IGM remain controversial. Previous case reports have suggested that hyperprolactinemia may be associated with
IGM. In the present report, we describe the first case of IGM associated with risperidone-induced
hyperprolactinemia.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/8120093785928228
Background
Idiopathic granulomatous mastitis (IGM) is a rare
benign breast disease characterized by non-caseating
granulomas without any evidence of infection. This dis-
ease was first described by Kessler and Wolloch in 1972
[1]. It usually affects young parous women with a his-
tory of breast-feeding. The clinical presentation is
usually a tender, erythematous breast mass with an
abscess or chronic sinus drainage. However, the clinical
and radiological features of this benign entity are fre-
quently mistaken for malignancy. Several etiologies of
IGM have been postulated, including immune reaction
to extravasated milk secretion, breast trauma, or infec-
tion [2,3]. Definitive diagnosis is based on histological
examination. Other causes of mammary granulomatous
formation must be excluded prior to diagnosis, and
microbiological investigation is necessary. Because of an
absence of a consensus for an appropriate treatment
modality for patients diagnosed with IGM, surgery, ster-
oids, immunosuppressants, and antibiotics have been
attempted with varying degrees of success. Recurrence is
common in the absence of surgical treatment, and a
long-term follow-up is generally essential.
Here we represent a case of granulomatous mastitis
associated with risperidone-induced hyperprolactinemia.
There have been only few cases associated with
hyperprolactinemia, and this case could be another one
belonging to this etiologic group.
Case Presentation
The patient in this study was a 39-year-old Chinese
woman who presented with a painful right breast lump
on April 5, 2008. She had a history of schizophrenia for
over 20 years and had been receiving risperidone (2 mg
bid) for more than 3 years. She had developed a lump
in her right breast a month before her visit and had
noted a progressive worsening tenderness with erythe-
matous changes around the lesion. She had no systemic
symptoms nor did she have any known previous fungus
or tuberculosis exposure. The patient had a gestational
history of G0P0 and had amenorrhea for approximately
a year. She had no history of any other breast disease or
receiving any breast surgery, and her medical history
was otherwise unremarkable. She had never consumed
tobacco, alcohol, oral contraceptive pills nor did she
have any family history of breast cancer. On physical
examination, a 9-cm × 6-cm breast lump with localized
redness over the right breast lateral aspect with an ill-
defined margin was noted with no palpable lymphade-
nopathy at the axilla. There was no splenomegaly or
hepatomegaly. She did not have fever, joint pain, airway
or urinary tract bleeding. No other skin lesion was
found. The patient’s blood count was normal. Breast
ultrasound images revealed a large ill-defined area with
heterogeneous echoes in the right upper and lower
outer quadrants, associated with increased vascularity.
Micro-calcification and tissue edema were noted. No
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there was no dilatation of the lactiferous duct. CXR
didn’t show any lung lesions. Mammography showed
asymmetry with increasing radiodensity at the outer
u p p e rq u a d r a n to ft h er i g h tb r e a s tw i t hn i p p l er e t r a c -
tion. Mastitis with edema and micro-abscess in the right
upper and lower quadrants was suspected. However,
inflammatory carcinoma could not be ruled out. All
other laboratory and other radiological studies including
C-reactive protein (0.8 mg/L) were normal except that
the prolactin level was 84.5 ng/ml (normal, < 20 ng/ml);
FSH, 4.6 mIU/ml; and LH, 6.0 mIU/ml. Although malig-
nancy had not been excluded, the patient received a pre-
sumptive diagnosis of infectious mastitis and was treated
w i t ha1 4 - d a yc o u r s eo fk e f l e x (first-generation cepha-
losporin), but there was no improvement. Therefore,
core breast biopsy was performed, which revealed an
adipose tissue with acute and chronic inflammation.
Aspiration culture showed no evidence of bacterial or
mycobacterial growth. In order to rule out previously
missed diagnosis, another incision biopsy was performed
1 week later, and the pathology showed chronic inflam-
mation with focal fibrotic changes in the fat tissues. Due
to persistent drainage with erythematous swelling and in
consideration of malignancy, the patient then was
scheduled for simple mastectomy. Macroscopic appear-
ance demonstrated a huge mass with an ill-defined mar-
gin of inflammatory tissue at the center with peripheral
fatty necrosis and hematoma (Figure 1). Microscopic
examination revealed chronic inflammation and macro-
phage, giant histiocyte, and epithelioid-like cellular infil-
tration, with cytologic features suggestive of a
granulomatous process. The noncaseous granulomatous
lesions were centered at the breast lobules. The lesions
were characteristic with an empty space in the center
and surrounded by microgranulomas and
Figure 1 A huge soft tissue mass (9 × 6 cm) with fibrosis, spotty necrosis, inflammation, and hemorrhage.T h ev i r t u a ls l i d e sf o rt h i s
article can be found here: http://diagnosticpathology.slidepath.com/dih/webViewer.php?snapshotId=1320701553, http://diagnosticpathology.
slidepath.com/dih/webViewer.php?snapshotId=1320701637, http://diagnosticpathology.slidepath.com/dih/webViewer.php?
snapshotId=1320701673, http://diagnosticpathology.slidepath.com/dih/webViewer.php?snapshotId=1320701702.
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of confluent epithelioid cells and huge abscess were also
seen (Figure 2A, B). Based on the histological features,
the differential diagnosis included autoimmune
response, undetected organisms, systemic granuloma-
tous disease with breast involvement, granulomatous
reaction in a carcinoma and foreign body reaction.
There was no evidence of carcinoma or specific organ-
ism can be found. All cultures, Ziehl-Neelsen staining,
PAS staining and GMS staining yielded negative results.
Considering the patient’s clinical history and all the
laboratory findings, the diagnosis was interpreted as
IGM. In suspect of the dopaminergic effect of risperi-
done to cause hyperprolactinemia and IGM, the pre-
scription was shifted to prolactin-sparing second line
agent (clozapine). The residual breast lesions resolved
completely 3 months later and no recurrence was noted
since then.
Discussion
Idiopathic granulomatous mastitis is characterized by
the presence of chronic granulomatous lobulitis. It is a
disease of unknown etiology and is diagnosed by exclu-
sion. Clinically, patients with IGM present a unilateral
hard lump in the absence of any systemic signs of infec-
tion. These lumps mimic carcinoma and may lead to
nipple retraction and sinus formation [1,2].
Approximately 200 cases of IGM have been reported
in the literature during the past 3 decades, with most of
them being reported in developing countries. More than
50% of the reported cases of IGM were initially mista-
ken for breast carcinoma, even with a combined diagno-
sis by mammography and ultrasound. A definitive
diagnosis can be made only through histological evi-
dence of granuloma formation with the absence of any
infection. A well-formed granuloma centered at the
terminal ducts and the lobules was noted, and this
could occur anywhere in the breast. A mixed chronic
inflammatory process composed of lymphocytes, plasma
cells, epithelioid histiocytes, multinucleated giant cells,
and a less frequent neutrophil infiltration with micro-
abscess formation can be found in the granuloma [3,4].
Before diagnosing IGM, any known cause of granulo-
matous breast inflammation, such as duct ectasia, sar-
coidosis, Wegener’s granulomatosis, giant cell arteritis,
polyarteritis nodosa, tuberculosis, syphilis, corynebacter-
ial infection, cat-scratch disease in breast lymph node
tissue, mycotic infection, granulomatous reaction in a
carcinoma and foreign body reaction, whether infectious
or non-infectious, should be ruled out [5-7]. Duct ecta-
sia can mimic IGM as both possess similar clinical
symptoms, including nipple retraction, pain, and occa-
sional bloody discharge. The dilation of the large duct
with peripheral duct inflammation, and not centered at
the breast lobules, is histologically evident. Sarcoidosis is
a systemic granulomatous disease of unknown etiology
with high prevalence rate in European countries. It
usually involves lung and associated lymph nodes and is
histologically characterized by well-formed tight granu-
lomas without necrosis, extensive inflammation, and
abscesses. The breast is involved in less than 1% of
cases [8]. Wegener’sg r a n u l o m a t o s i si saf o r mo fl a r g e -
size vasculitis that usually affects upper airway, lung and
kidney. It is featured as an autoimmune attack by an
abnormal type of circulating antibody termed ANCAs
(antineutrophil cytoplasmic antibodies). The histological
presentation is small and medium vessel vasculitis with
necrotizing granulomas. Breast involvement is rare and
usually accompanied by systemic manifestations of the
disease [9,10]. Polyarteritis nodosa and giant cell arteritis
are occasionally classified as vasculitis, but actually are a
form of arteritis since they mainly involve the arteries.
Granulomatous response to carcinoma is unusual and
characterized by multinucleated giant cells restricted to
the carcinoma or osteoclastic giant cells (OGCs) at per-
ipheral hypervascular stroma. These two types have
been easily identified with intraductal or invasive carci-
noma [11,12]. Foreign body reaction may be due to sili-
con leakage from breast implant. Although there are no
risks of systemic disease or carcinogenesis, the relation-
ship between silicon breast implant and primary ana-
plastic large cell lymphoma (ALCL) of the breast has
been reported [13]. Culture specimens and special stain-
ing of specimens, including Ziehl-Neelsen staining, PAS
staining, GMS staining, and Warthin-Starry silver
impregnation, can rule out rare infectious granuloma-
tous breast lesions.
The presumptive causes of IGM, including alpha-1-
antitrypsin deficiency, oral contraceptives usage, preg-
nancy, lactation, and hyperprolactinemia have been
reported [2,6,14,15]. Interestingly, hyperprolactinemia
whether primary or secondary, might play an important
role in IGM. It has been postulated that IGM results
from a localized autoimmune response to the retained
or extravasated fat- or protein-rich secretion in the
breast ducts during childbearing age due to a previous
hyperprolactinemia in women [16]. To the contrary, as
the occurrence of IGM without a history of recent preg-
nancy is uncommon, the serum prolactin level and the
pathogenesis of IGM in non-pregnant women therefore
might help us understand the role of hyperprolactinemia
in the disease. Especially, the role of hormone in mam-
mary tumor growth is under investigated and with some
trigger agents, such as environmental contaminants, the
increase of hormone receptors can promote cell prolif-
eration [17]. To the best of our knowledge, IGM in
non-pregnant women associated with high serum pro-
lactin level can has been rarely reported associated with
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Page 4 of 6pituitary adenoma, phenothiazine-induced hyperprolacti-
nemia, and metoclopramide-related galactorrhea with
blunt trauma [16,18-20]. Our case is the fourth one in a
non-pregnant woman with hyperprolactinemia and is
the first case to be reported that the hyperprolactinemia
was induced by risperidone.
Many antipsychotic agents are known to increase pro-
lactin secretion because of their inhibitory effect of
dopamine. Risperidone is known to increase serum pro-
lactin level to a greater extent than other antipsychotics,
such as quetiapine. It is thought that once the prolactin
level is elevated due to risperidone, it causes non-can-
cerous tumors in the pituitary gland. This has been
demonstrated to recur even after the drug has been
switched to a different class of antipsychotic agents
[21,22]. Interestingly, over the past decades, several stu-
dies have specifically examined the relationship between
prolactin levels and granulomatous diseases. These stu-
dies suggest that prolactin contributes to a wide variety
of both physiological and pathological granulomatous
cutaneous lesions, especially those of immune response,
such as the non-caseating granulomas [23,24]. The clini-
cal presentation of IGM patients is similar, despite the
varied causes behind the laboratory evidence of hyper-
prolactinemia or galactorrhea. Based on these findings,
hyperprolactinemia and/or galactorrhea along with other
superimposing causes, such as local trauma or irritation
may be the sequential features that result in IGM.
There is no consensus regarding the ideal manage-
ment of IGM. A conservative non-operative treatment is
usually recommended for IGM patients with mild symp-
toms [25]. Therapy is recommended for patients with
drug-induced hyperprolactinemia, and these patients are
usually shifted to a prolactin-sparing agent. For patients
with more severe symptoms, oral prednisolone is admi-
nistered [26]. Immunosuppressants may be effective in
refractory cases of the above regimens [27,28]. Finally,
in persistent or recurrent cases, wide surgical excision
and/or mastectomy should be considered [2,29].
Conclusions
Idiopathic granulomatous mastitis is an uncommon
benign entity of the breast with a diagnosis exclusive of
malignancy and infectious etiology. In this study, we
report a case with this mysterious entity in a non-preg-
nant woman with a laboratory evidence of hyperprolac-
tinemia due to risperidone usage. Investigating more
number of case reports and further assessments are
necessary for understanding the relationship between
hyperprolactinemia and IGM.
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